| Mary K Henthorn, OT | |
|
29 Thorne Hill Dr, Florence, KY 41042-8928 | |
| (937) 570-1933 | |
| Not Available |
| Full Name | Mary K Henthorn |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Feeding, Eating & Swallowing |
| Location | 29 Thorne Hill Dr, Florence, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114208048 | NPI | - | NPPES |
| 2187155 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XF0002X | Occupational Therapist - Feeding, Eating & Swallowing | 007519 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary K Henthorn, OT 29 Thorne Hill Dr, Florence, KY 41042-8928 Ph: (937) 570-1933 | Mary K Henthorn, OT 29 Thorne Hill Dr, Florence, KY 41042-8928 Ph: (937) 570-1933 |
News Archive
Today Omixon – a genomic software company - announced the commercial release of Omixon Target, a next generation sequencing analysis software for targeted sequencing. Omixon built its new software Target with the vision of helping diagnostic labs to adopt next generation sequencing to replace and complement traditional capillary Sanger sequencing.
A new study from the researchers at the University of California, Berkeley has shown that progressively declining quality of sleep among those in their 50s and 60s could be indicative of protein tangles within their brains that could lead to later development of Alzheimer's disease.
About 1 in 10 people have the potential to develop schizophrenia, but only 1 in 100 actually end up with this devastating illness. The challenge is in knowing why some do and some don't.Drawing from over 25 years of laboratory study, Mark F. Lenzenweger, a distinguished professor of clinical science, neuroscience and cognitive psychology at Binghamton University, thinks that not only does he have the makings of a good response to this troubling question but also how to go about finding those answers.
The overall survival of most people with chronic myelogenous leukemia (CML) treated with imatinib (Gleevec, STI-571) is extremely high and the relapse rate is quite low, according to new data from a study out of the Oregon Health & Science University Cancer Institute.
Oxford Gene Technology, The Molecular Genetics Company, has made several advances in hybridisation-based target enrichment protocols that now enable researchers to prepare samples for sequencing in just one day.
› Verified 6 days ago
Jill Ellen Lessig, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7300 Woodspoint Dr, Florence, KY 41042 Phone: 859-371-5731 Fax: 859-371-4033 | |
Maria Danielle Surface, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7627 Ewing Blvd, Florence, KY 41042 Phone: 859-534-1833 | |
Karen Prophet Tindall, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 31 Spiral Dr, Florence, KY 41042 Phone: 859-525-1128 Fax: 859-525-0271 | |
Mrs. Maureen Sheehy Dragone, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3063 Danbury Dr, Florence, KY 41042 Phone: 859-250-1519 | |
Haley G Raben, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7665 Ewing Blvd, Florence, KY 41042 Phone: 812-319-4776 | |
Richelle Margaret Yost, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7627 Ewing Blvd, Florence, KY 41042 Phone: 859-283-1500 |